KaydedilenlerDerginizi ekleyin

Dergiler / Eastern Journal of Medicine / 2022 / Cilt: 27 - Sayı: 1

P Wave Dispersion in COVID-19

Mustafa TUNCER
Fatih ÖZTÜRK
Rabia ÇOLDUR
Medeni KARADUMAN
Yılmaz GÜNEŞ
Sayfa
91–94
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Increased Pd was observed as an indication that COVID-19 affects the atriums.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The effects of COVID-19 on the heart are still not fully known.
📊
Temel Bulgular & Veri:In this study, we investigated how COVID-19 affects the P interval.
💡
Sonuç & Katkı:Increased Pd was observed as an indication that COVID-19 affects the atriums.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

The effects of COVID-19 on the heart are still not fully known. In this study, we investigated how COVID-19 affects the P interval. Electrocardiographies (ECG) of 30 COVID-19 patients and the control group consisting of 23 healthy volunteers were examined and dispersion (Pd) of the P wave was calculated. Compared to control group mean Pd (40,1±6,6 vs. 49,6±11,5, p=0,006) values were significantly higher in Covid19 patients. Increased Pd was observed as an indication that COVID-19 affects the atriums.

🔖

Bu Makaleye Atıf Yap

TUNCER, M., ÖZTÜRK, F., ÇOLDUR, R., KARADUMAN, M., GÜNEŞ, Y. (2022). P Wave Dispersion in COVID-19. Eastern Journal of Medicine, Cilt: 27 - Sayı: 1, 91–94. https://ajindex.com/articles/493403

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Kapoor A, Pandurangi U, Arora V, Gupta A, Jaswal A, Nabar A, et al. Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society. Indian Pacing Electrophysiol J. 2020
  2. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA cardiology. 2020
  3. Guo T, Fan Y, Chen M. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;27
  4. Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA cardiology. 2020
  5. Bessiere F, Roccia H, Deliniere A, Charriere R, Chevalier P, Argaud L, et al. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit. JAMA cardiology. 2020
  6. Members ATF, Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association. European heart journal. 2012;33(21):2719-47
  7. Dilaveris PE, Gialafos JE. P wave dispersion: A novel predictor of paroxysmal atrial fibrillation. Annals of Noninvasive Electrocardiology. 2001;6(2):159-65
  8. Perzanowski C, Ho AT, Jacobson AK. Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. Journal of electrocardiology. 2005;38(1):43-6
  9. Gurok MG, Korkmaz H, Yıldız S, Bakış D, Atmaca M. QT and P-wave dispersion during the manic phase of bipolar disorder. Neuropsychiatric disease and treatment. 2019;15:1805
  10. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. European Heart Journal–Cardiovascular Imaging. 2013;14(7):611-44
  11. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic dis